The FDA has issued warning letters to 15 companies for illegally selling products containing CBD in ways that violate the Federal Food, Drug, and Cosmetic Act. The FDA has also published a revised Consumer Update detailing the safety concerns about CBD products more broadly.
“As we work quickly to further clarify our regulatory approach for products containing cannabis and cannabis-derived compounds like CBD, we’ll continue to monitor the marketplace and take action as needed against companies that violate the law in ways that raise a variety of public health concerns,” said FDA Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D, in a statement.
Related: Jones Soda Exploring CBD Beverage Line; Southeastern Grocers Adds CBD Products to Offerings.
from Industry Operations https://ift.tt/2QZPvia
No comments: